Episoder
-
How do we optimize our bodies and our brains for learning new things? In this episode of The Psychedelic Report, Dr. Dave Rabin welcomes back nutritional biochemist Shawn Wells to explore the often-overlooked topic of post-psychedelic supplementation. They discuss how to optimize the benefits of psychedelic experiences and ensure that the transformations achieved during these journeys can last longer.
Shawn shares his expertise on various supplements, nutrients, and dietary strategies that can enhance neuroplasticity, support mental health, and promote overall well-being after a psychedelic experience. The conversation covers essential topics such as hydration, the role of adaptogens, the importance of neurotransmitter repletion, and the impact of diet on recovery.
Tune in for valuable insights from leading experts in the field of Psychedelic Medicine.
Optimizing Psychedelic Medicine Experiences with Shawn Wells
Web: https://shawnwells.com/Instagram: https://www.instagram.com/shawnwellsTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com -
In this episode, Dr. Dave Rabin discusses the impact of the FDA's decision, the potential delays in accessing this crucial treatment, and the unethical behavior of certain organizations influencing the FDA. Dr. Rabin is joined by Jon Lubecky, a retired army sergeant and Veteran who took part in MAPS MDMA therapy trials, as he discusses the implications of this rejection and emphasizes the need for ongoing advocacy and hope for eventual approval. The episode also addresses the unethical behavior of Symposia, an organization accused of falsifying information to the FDA to obstruct MDMA therapy approval. Additionally, former Symposia member David Nichols reveals serious ethical violations within the organization, raising questions about their motives and funding. Through these discussions, the episode highlights the critical need for transparency, ethical practices, and continued efforts to ensure access to psychedelic treatments for those in need.
Rachel Nuwer’s Scientific American Article: https://www.scientificamerican.com/article/fdas-rejection-of-mdma-psychotherapy-for-trauma-draws-criticism-from/
Jon Lubecky’s Conversation with David Nickles on Breaking Points: https://www.youtube.com/watch?v=lttFB0c0cAo
Web: https://psychedelic.support/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Food and Drug Administration5630 Fishers LaneRm. 1061Rockville, MD 20852Docket No. FDA-2024-N-193 -
Mangler du episoder?
-
In this episode, Dr. Dave Rabin is joined by Dr. John J. Miller, a renowned clinical psychopharmacologist, to discuss the significance of the upcoming FDA decision on MDMA therapy for PTSD.
John J. Miller, M.D. is Medical Director at Brain Health in Exeter, New Hampshire and has served as the Editor-in-Chief for Psychiatric Times since February 2019. He has worked for 38 years as a clinical psychopharmacologist, most recently 17 years as a Staff Psychiatrist at Seacoast Mental Health Center in Exeter, NH. Dr. Miller completed his B.S. in Biochemistry at the University of MA/Amherst. And medical school and residency in Adult Psychiatry at the University of MA Medical School/Worcester. He is a Diplomate of the American Board of Psychiatry and Neurology. Since 1998 he has presented more than 3,000 lectures throughout the US on a wide range of psychiatric topics including PTSD. You can find Dr. Miller in his monthly editorials for Psychiatric Times that he has been authoring since March 2019.
Discover the history of PTSD treatment, the current limitations of existing medications, and the promising results of MDMA-assisted therapy trials. Learn about the bipartisan support from lawmakers and the urgent need for FDA approval to provide relief to millions suffering from PTSD.
Don't miss this insightful conversation on the potential paradigm shift in mental health treatment. Stay informed and advocate for change by tuning in to The Psychedelic Report.
Brain Health in Exeter, New Hampshire (http://www.brain-health.co)
Psychiatric Times (http://www.psychiatrictimes.com)
https://x.com/PsychTimes?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
https://www.linkedin.com/in/jjmillermd/
https://www.linkedin.com/company/psychiatric-times/
www.apolloneuro.com
FDA petition for MDMA-assisted therapy
https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/ -
In this episode, Dr. Dave Rabin MD, PhD is joined by Dr. Geoff Bathje PhD who authored an article published on July 19, 2024 in Chacruna entitled: “The Unbelievable Claims of Psymposia about MAPS and MDMA-Assisted Therapy.”Dr. Bathje and Dr. Rabin discuss the recent FDA Advisory Committee vote on MDMA-assisted therapy for PTSD, which surprisingly and wrongfully concluded that the benefits do not outweigh the risks. This conversation deep dives into Dr. Bathje’s report on how Psymposia, what appears to be a group of fringe radicals, negatively biased the FDA committee's vote on June 4 by writing letters with false and misleading claims in an attempt to prevent the clearance of MDMA for PTSD. Why would anyone not only want to prevent clearance of MDMA therapy for Veterans, but see themselves as heroes for doing so? Find out all that and more in this weeks episode of The Psychedelic Report.
The Unbelievable Claims of Psymposia about MAPS and MDMA-Assisted Therapy by Dr. Geoff Bathje: https://chacruna.net/unbelievable-claims-of-psymposia-about-maps-and-mdma-assisted-therapy/
Web: https://psychedelic.support/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/
FDA petition for MDMA-assisted therapy https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/
Food and Drug Administration5630 Fishers LaneRm. 1061Rockville, MD 20852Docket No. FDA-2024-N-193 -
In this episode of The Psychedelic Report, Jesse Gould, Veteran Army Ranger and Founder of the Heroic Hearts Project, joins Dr. Dave Rabin to explore the implications of the recent FDA advisory committee vote on MDMA-assisted therapy for Veterans with PTSD. They highlight concerns over the influence of non-objective groups on the committee's decision and discuss the potential impact on millions of individuals seeking effective treatment for mental health challenges.
Join the conversation as they explore the implications of disrupting the progress of a groundbreaking treatment and the importance of advocating for evidence-based therapies. Learn how you can get involved and make your voice heard to support the advancement of MDMA-assisted therapy for those who need it most.
To take action and stay informed, visit Heroic Hearts and sign up for updates on upcoming initiatives. Let's come together to ensure access to life-changing treatments for Veterans and individuals suffering from PTSD.
Don't miss this insightful discussion on the intersection of medicine, advocacy, and the future of psychedelic therapies. Subscribe to The Psychedelic Report for more thought-provoking episodes on the latest developments in psychedelic medicine and healing.
FDA petition for MDMA-assisted therapy https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/
Food and Drug Administration
5630 Fishers Lane
Rm. 1061
Rockville, MD 20852
Docket No. FDA-2024-N-193
Web: https://heroicheartsproject.org/our-story/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com -
In this compelling episode of The Psychedelic Report, Dr. Dave Rabin delves into the evolving landscape of psychedelic-assisted therapies with special guest Jon Lubecki, a veteran and prominent advocate for such treatments in Ukraine. The discussion centers on the recent FDA advisory committee setback, which resulted in a 10 to 1 vote against MDMA-assisted therapy due to lingering concerns about its safety and efficacy, particularly in post-treatment activities like driving. Jon provides a nuanced analysis of the hearing, pointing out significant conflicts of interest among some opponents who failed to disclose their affiliations with competing therapies like psilocybin and ketamine. He also examines the critical role of influential organizations such as ICER and Symposia, whose biased reports have swayed public and regulatory opinions against MDMA trials. With a fervent focus on the broader implications for mental health, especially for veterans suffering from PTSD, Jon underscores the inadequacy of current treatments and the transformative potential of MDMA-assisted therapy. He shares his personal journey from struggling with PTSD to becoming a leading advocate, passionately calling for the democratization of access to these promising therapies, transcending political and social boundaries.
Instagram: https://www.instagram.com/jonathanlubecky/Web: www.mdmaptsd.orgTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com
Congressman Dan Crenshaw speaks out on the MDMA-assisted therapy controversy and the anti-Veteran agenda :
https://www.instagram.com/reel/C8zsu2Wu7M0/?utm_source=ig_web_copy_link&igsh=MzRlODBiNWFlZA==
FDA petition for MDMA-assisted therapy https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/
Food and Drug Administration
5630 Fishers Lane
Rm. 1061
Rockville, MD 20852
Docket No. FDA-2024-N-193 -
In the latest episode of The Psychedelic Report, Dr. Dave Rabin shares the latest news on the MDMA-Assisted Therapy trials evaluation by the FDA Advisory Committee from June 4, who voted a surprising 10-1 that the risks of this breakthrough treatment outweigh the benefits. This was particularly astonishing to clinicians and researchers as described by Rachel Nuwer in her latest article in the BBC published on June 20. We’ll take a deep dive into this article and the discussion of safety and risks of MDMA-Assisted Therapy, followed by an enlightening conversation with award-winning author Tucker Max about his personal journey achieving a greater sense of safety with psychedelic-assisted therapy.
Tucker discusses the importance of safety and integration practices in maximizing the benefits of psychedelic experiences. He emphasizes the role of journaling, psychotherapy, and lifestyle changes in supporting the integration process and facilitating personal growth. Tucker's journey highlights the profound impact of psychedelics on mental health, self-discovery, and relationships.
Don't miss this insightful episode, where real-life experiences and expert perspectives converge to explore the healing potential of psychedelic medicines. Tune in now to embark on a journey of self-discovery and transformation with Tucker Max.
Web: https://www.tuckermax.com/
Twitter: https://twitter.com/DrDavidRabin
Instagram: https://www.instagram.com/drdavidrabin
Web: https://www.drdave.io/
Web: www.ApolloNeuro.com
Tucker’s Books: https://www.tuckermax.com/books/#:~:text=Tucker%20Max's%20first%20three%20books,success%20has%20meant%20his%20success.
Article: FDA advisors voted against MDMA therapy – researchers are still fighting for it
https://www.bbc.com/future/article/20240620-fda-advisors-voted-against-mdma-therapy-researchers-are-still-fighting-for-it
Your Brain Explained Episode 1 - The MDMA Breakthrough: https://open.spotify.com/episode/4k4KWRzmn8o8N2Aer4MYAG?si=0377e20f02ed481d
Rachel Nuwer’s NYT article breaking the study findings: https://www.nytimes.com/2023/09/14/health/mdma-ptsd-psychedelics.html
Nature Medicine MDMA trial science article 1: https://www.nature.com/articles/s41591-021-01336-3
Nature Medicine MDMA trial science article 2: https://www.nature.com/articles/s41591-023-02565-4
Special episode of The Tim Ferriss Show with Dr. Dave Rabin on MDMA Therapy: https://open.spotify.com/show/5qSUyCrk9KR69lEiXbjwXM
Food and Drug Administration
5630 Fishers Lane
Rm. 1061
Rockville, MD 20852
Docket No. FDA-2024-N-193 -
In this compelling episode of The Psychedelic Report, Dr. Dave Rabin is joined by esteemed journalist Rachel Nuwer, renowned for breaking the pivotal story on the Phase 3 MDMA-assisted therapy trials for PTSD in The New York Times. Together, they delve into the recent contentious votes from the FDA Pharmacologic Advisory Committee, which advised against approving MDMA-assisted therapy despite robust evidence from clinical trials.
Rachel provides an insider's perspective on the committee's decision, expressing disappointment over the unreasonably high standards applied to MDMA-assisted therapy compared to other psychiatric medications. She and Dr. Rabin discuss the committee's focus on issues like demographic representation and the integration of therapy with MDMA treatment, arguing that these criticisms overlook the proven benefits of MDMA in enhancing psychotherapy outcomes.
The episode highlights the need for better education on psychedelic therapy within the medical community and critiques the media's role in spreading public misconceptions. Rachel and Dr. Rabin emphasize the potential of MDMA-assisted therapy to revolutionize PTSD treatment, especially for Veterans and other underserved populations. Despite the setback, they remain hopeful that the scientific evidence and patients’ needs will ultimately prevail.
Overall, the conversation underscores the importance of accurate reporting and increased awareness to advance psychedelic therapies and build public trust in these innovative treatments.
Your Brain Explained - Can We Cute Mental Illness? The MDMA Story
Apple: https://podcasts.apple.com/us/podcast/your-brain-explained/id1693658383?i=1000617879818
Spotify:
https://open.spotify.com/episode/4k4KWRzmn8o8N2Aer4MYAG?si=fd8c315823854dad
Rachel Nuwer’s Breaking News on MDMA Phase 3 Trials Results in the NYT:
https://www.nytimes.com/2023/09/14/health/mdma-ptsd-psychedelics.html
Rachel Nuwer’s book I Feel Love: MDMA and the Quest for Connection in a Fractured World https://www.goodreads.com/book/show/62039306-i-feel-love
Twitter: https://twitter.com/DrDavidRabin
Instagram: https://www.instagram.com/drdavidrabin
Web: https://www.drdave.io/
Web: www.ApolloNeuro.com -
In this episode of The Psychedelic Report, Dr. Dave Rabin explores the nexus of nutrition, supplementation, and optimizing psychedelic medicine experiences with Shawn Wells, an expert in diet, nutrition, and biochemistry. Shawn discusses the transformative impact of psychedelics on his life and emphasizes the importance of practices like fasting and dietary restriction to establish an optimal physiological baseline for meaningful journeys. They discuss how fasting can induce a ketogenic state, potentially enhancing neuroplasticity during psychedelic experiences. This conversation emphasizes the significance of preparation, both physically and mentally, for psychedelic experiences, highlighting the importance of adaptability, stress tolerance, and learning.
Web: https://shawnwells.com/Instagram: https://www.instagram.com/shawnwellsTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com -
In this episode of The Psychedelic Report, Dr. Dave Rabin and Dr. Amy Killen delve into the profound correlation between sexuality, intimacy, and longevity. Dr. Killen, a physician, presents compelling research demonstrating that regular sexual activity is associated with reduced mortality rates, particularly in men, attributing this effect to the physiological impact of sexual experiences, including the release of neurotransmitters like dopamine, endorphins, serotonin, and oxytocin. They advocate for a comprehensive approach to sexual education, emphasizing self-exploration, effective communication, and the destigmatization of pleasure. This episode addresses societal taboos around sexuality and underscores the importance of prioritizing sexual health in healthcare practices. Overall, they challenge listeners to adopt a more open-minded and holistic perspective on sexuality, recognizing its profound impact on overall well-being and quality of life.
Web: https://dramykillen.com/Instagram:https://www.instagram.com/dr.amybkillen/Facebook: https://www.facebook.com/DrAmyBKillen/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com -
How can individuals improve their understanding of their capabilities and potential, particularly in the context of stress management and mindfulness practices?
In this episode, Dr. Dave Rabin interviews Jeff Krasno, founder of Commune and a prominent figure in the health and wellness community, joins the discussion on stress, delineating between chronic distress and beneficial stress rooted in evolutionary pressures. Through Jeff's curated protocols, including intermittent fasting, cold therapy, and social experiments, listeners gain insight into harnessing the power of good stress to enhance physiological and psychological health. The conversation delves into the physiological benefits of good stress, the importance of optimal stress dosage, and the parallel between building psychological resilience and strengthening the immune system. Jeff emphasizes the role of attention control in shaping reality and advocates for meditation and mindfulness practices to cultivate it. The episode concludes with a reflection on embracing discomfort and life's uncertainties, including death, as avenues for growth and self-discovery through meditation and psychedelic exploration.
Listeners can find Jeff Krasno on the Commune podcast and Instagram, with his course on good stress available on Commune's website, reflecting his mission to democratize access to transformative practices.
Web: https://www.jeffkrasno.com/commune-podcastInstagram: https://www.instagram.com/jeffkrasno/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com -
How can we improve our self-awareness and enter altered states of consciousness to live more fully? Join Dr. Dave Rabin and Dave Asprey as they delve into a fascinating discussion on various methods for accessing altered states of consciousness and enhancing self-awareness. They explore practices such as breathwork, neurofeedback, psychedelics, tantra, and conscious kink, among others, emphasizing the diverse range of tools available for personal growth and transformation.
Dave Asprey shares profound insights into the process of resetting trauma and the importance of gratitude and forgiveness in healing. He explains that forgiveness is not about condoning the actions of others but about releasing reactivity and cultivating inner peace. Gratitude, often overlooked in therapeutic practices, is highlighted as a crucial step towards self-trust and personal growth.
This episode addresses common concerns about personal transformation and reassures listeners that growth and change are natural processes that can lead to greater happiness and fulfillment.
Web: https://40yearsofzen.com/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com -
What happens when we explore the intersection of psychedelic medicines and healing? In this episode, Dr. Dave Rabin and Dr. Jeff Chen embark on a journey through the landscape of psychedelic drugs, from their historical roots in America's counterculture to their re-examination for therapeutic purposes today. Delving into the challenges of conducting research on psychedelic substances, particularly under regulatory restrictions, they shed light on the potential of cannabis for psychedelic-assisted therapy. Join them as they discuss the evolving field of psychedelic research, touching on crowd-sourced studies, decriminalization, and the crucial integration of therapy with psychedelic experiences. This episode provides a comprehensive overview of the current state of psychedelic research, the challenges and opportunities in the field, and the potential for these substances to revolutionize mental health treatment. Join Dr. Dave Rabin and Dr. Jeff Chen as they navigate the complex and fascinating world of psychedelic medicines and healing.
Web: https://radiclescience.com/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com -
Can psychedelics and sexuality transform healing? Can we access powerful psychedelic states through intimacy, connection, and sexual experiences? What happens when you combine psychedelic medicines and sex? In this special Valentines Day episode of The Psychedelic Report, Dr. Dave Rabin is joined by Jaiya, renowned expert in sexual healing and empowerment to explore the transformative power of psychedelic experiences and their potential to heal trauma, enhance sexual experiences, and much more! Jaiya shares her personal journey of healing and how she discovered the profound connection between sexuality, psychedelics, and trauma healing. They dive into the concept of trauma and its impact on the brain, as well as the importance of creating safety and consent in both psychedelic experiences and sexual encounters. This episode also touches on the role of intention in psychedelic and sexual experiences, the power of pleasure as a healing tool, and the need for a code of ethics in psychedelic use that includes the exploration of sexuality. Jaiya leaves us with the concept of the five erotic blueprints, providing insights into different types of sexual expression and how they can be integrated into healing and personal growth. If you’ve ever had questions about sexuality and intimacy and how to invite more of it into your life, this is the show for you!
Web: https://theblueprintbreakthrough.com/book/Instagram: https://www.instagram.com/missjaiya/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com -
How do the ancient traditions shed light on the interplay between science, spirituality, and the transformative journey of self-discovery? In this episode, Dr. Dave Rabin and Katie Silcox explore the fascinating intersection of science and spirituality. Katie, with an extensive background in Hinduism and Ayurveda, shares her journey into the world of tantric and yogic traditions. They discuss how these traditions aim to expand the mind beyond our limitations, emphasizing practices like breathing for inner exploration. The conversation touches on how these practices actually change our bodies, including Kundalini awakening and the balance of inner feminine and masculine aspects. They also explore the importance of grounding, self-acceptance, and the rise of the divine feminine in modern spirituality. Overall, this episode continues our 2024 exploration into the intricate connections between science and spirituality, providing a holistic understanding of consciousness and the deep interplay between mind, body, and ancient wisdom.
Web: https://theshaktischool.com/Instagram: https://www.instagram.com/theshaktischool/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com -
How do you define sobriety?
This week's episode features an enlightening discussion with biohacking influencer and interviewer Luke Storey about his personal journey with addiction, recovery, and the mindful integration of plant medicines.
Luke shares vulnerably about the childhood trauma that led him down a path of substance abuse, and how eventually hitting rock bottom inspired his sobriety 24 years ago.
He explained his thoughtful process around redefining sobriety and abstinence as he began to explore the healing potential of psychedelics like ayahuasca.
Luke and Dr. Dave Rabin have an insightful conversation about the difference between substances that disconnect us from consciousness versus those that can open portals to personal and spiritual growth.
They explored the importance of set, setting, intention, and integration when working with plant medicines. Join us for this thought-provoking look at how psychedelic medicines, when used consciously, can catalyze awe, disrupt negative thought patterns, reveal deeper layers of healing, and may provide a glimmer of hope for addiction treatment in the 21st century.
Web: https://www.lukestorey.com/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/ -
Join us for a thoughtful conversation between expert panelists in the fields of psychology, neuroscience, meditation, and psychedelics, recorded live at Open studio in Venice, California. Led by Apollo Neuro co-founder and Chief Medical Officer Dr. Dave Rabin, MD, PhD, with Manoj Dias, co-founder of Open, and Lauren Swanson, the Director of Patient Care at Wondermed Health, which provides ketamine treatment for anxiety and depression, they discuss where mindful practices like meditation and breathwork, psychedelic medicine, and wearable health overlap and where they differ, and how these practices can be used in tandem for healing and growth.
Learn more about Apollo Neuro here.
Download Open's mindfulness app here.
Discover more about Wondermed here. -
Is the field of psychedelic therapy receiving the educational support it needs? In this episode, Dr. Dave Rabin engages in a thought-provoking conversation with Dr. Allison Feduccia, a neuropharmacologist and the founder of Psychedelic Support. They explore the organization's mission, which includes providing crucial resources, a directory of licensed health professionals, and ACCME-accredited online courses covering substances like MDMA, psilocybin, and ketamine. The episode sheds light on the hurdles Psychedelic Support faces in obtaining ACCME accreditation for their courses, raising concerns about the impact on education accessibility. The dialogue encompasses the FDA's warning on ketamine treatments, its contradictory extension through telehealth by the DEA, and Dr. Allison Feduccia's personal journey with ayahuasca, leading to her involvement in equine facilitated services and the development of a course on equine therapy. As they discuss the potential changes in accreditation, Dr. Allison emphasizes the significance of clinicians taking these courses and supporting organizations like Psychedelic Support in advancing psychedelic therapy education.
Web: https://psychedelic.support/
ACCME Web:https://www.accme.org/
https://www.instagram.com/accreditedcme
Contact number: (312) 527-9200
Twitter: https://twitter.com/DrDavidRabin
Instagram: https://www.instagram.com/drdavidrabin
Web: https://www.drdave.io/ -
Have you ever wondered about the real-world impact of microdosing psychedelics? In this episode, Dr. Dave Rabin interviews Dr. Pamela Kryskow and Dr. Zach Walsh, investigators on the Microdose.me study—one of the world's largest real-world studies on people microdosing psychedelics. Dr. Kryskow and Dr. Walsh discuss their backgrounds and entry into the psychedelic space, emphasizing the importance of observing real-world experiences. The Microdose.me study aims to provide substantial clinical data to support this promising new area of research. Their findings highlight positive outcomes for microdosers, including cognitive benefits for individuals over 55. The researchers stress the challenges of real-world studies, the need for collaboration, and the study's potential to guide future clinical trials.
Web: Microdose.meTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/ -
In this episode Dr. Dave Rabin had the privilege of speaking with the late Dr. Roland Griffiths, a renowned figure in the field of psychedelic science and medicine. Dr. Griffiths, who passed away on October 16, 2023, was a pioneer in the study of consciousness and the therapeutic potential of psychedelic medicines. Dr. Griffiths was the Director of the Center for Psychedelic and Consciousness Research at Johns Hopkins University School of Medicine, shares his journey into the field, driven by his interest in meditation and altered states of consciousness. His groundbreaking research on psilocybin, the active compound in magic mushrooms, is discussed, highlighting the profound effects it induces, including mystical experiences and psychological insights. Dr. Griffiths underscores the need for further research into the variations among different strains of psilocybin mushrooms and the future of psychedelic therapy, which may involve novel compounds and therapeutic approaches. This episode provides valuable insights into the potential of psilocybin mushrooms for depression treatment and the ongoing advancements in psychedelic medicine.
Web: https://hopkinspsychedelic.org/griffithsTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/ - Se mer
